Strategic inertia and the Japanese pharmaceutical industry

Slater, Stephanie ORCID: https://orcid.org/0000-0001-9817-3687, Paliwoda, Stan and Slater, Jim 2008. Strategic inertia and the Japanese pharmaceutical industry. Multinational Business Review 16 (4) , pp. 1-24. 10.1108/1525383X200800016

Full text not available from this repository.

Abstract

This paper examines the behaviour of Japanese pharmaceutical corporations in the light of recent merger activity, questioning strategic momentum theory given the particularly significant influence of culture on the decision-making process in this market. The international performance of Japan’s pharmaceutical industry has been poor; therefore, we examine the regional orientation of the top global pharmaceutical TNCs, inquiring as to why there has not been greater convergence among Triad countries. Irrespective of cultural differences, this industry has been slow to respond to international macro change, but mergers, acquisitions, and other convergence strategies are now being observed.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Business (Including Economics)
Subjects:	H Social Sciences > H Social Sciences (General) H Social Sciences > HD Industries. Land use. Labor H Social Sciences > HD Industries. Land use. Labor > HD28 Management. Industrial Management H Social Sciences > HF Commerce R Medicine > RM Therapeutics. Pharmacology
Uncontrolled Keywords:	Acquisitions ; International performance ; Japan ; Merger ; Pharmaceutical industry
Publisher:	Emerald
ISSN:	1525-383X
Last Modified:	19 Oct 2022 09:08
URI:	https://orca.cardiff.ac.uk/id/eprint/20095

Actions (repository staff only)

Edit Item